CVE-2023-38955
ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to obtain sensitive information...
ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to obtain sensitive information about all managed devices, including their IP addresses and device names.
Attack profile
How easy it is to exploit
- Attack vector
- Network
- Complexity
- Low
- Privileges needed
- None
- User interaction
- None
What an attacker can affect
- Confidentiality
- High
- Integrity
- None
- Availability
- None
Exploit likelihood
What each source reports
NVD Score used
ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to obtain sensitive information about all managed devices, including their IP addresses and device names.
- Record
CVE-2023-38955- CVSS 3.1
- 7.5 High
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N - Weakness
- CWE-668
- Updated
- 2026-11-02
CVE List No score
ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to obtain sensitive information about all managed devices, including their IP addresses and device names.
- Record
CVE-2023-38955- Updated
- 2026-11-02
EUVDEUVD-2023-42715 No score
ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to obtain sensitive information about all managed devices, including their IP addresses and device names.
- Record
EUVD-2023-42715- Updated
- 2026-11-02
GitHub AdvisoriesGHSA-4c47-49qq-pq45
ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to obtain sensitive information...
ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to obtain sensitive information about all managed devices, including their IP addresses and device names.
- Record
GHSA-4c47-49qq-pq45- CVSS 3.1
- 7.5 High
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N - Weakness
- CWE-668
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| first indexed | CVE List, EUVD, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2023-38955 is a high vulnerability (CVSS 7.5) in Zkteco Bioaccess Ivs, published August 3, 2023. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.60%, the 48th percentile. No source names a fixed version.